Friday August 14, 2020

Medical device firm delists from stock market

The move comes due to poor liquidity in Mainstay’s shares, very few of which were actively traded

Ian Guider

Markets Editor

@ianguider
7th June, 2020
Mainstay has said that the delisting from Dublin, and also the Paris stock market, was down to the poor liquidity in its shares

Mainstay, the medical device maker, has had its plans to delist from the Dublin stock market approved by the High Court, ending its short life as a public company.

Mainstay has said that the delisting from Dublin, and also the Paris stock market, was down to the poor liquidity in its shares with very few actively traded, which depressed its value. The delisting means investors will receive one new share for every one they currently...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

This product does not auto-renew

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

Hammerson, owner of a number of Irish shopping centres, is to use land it owns near the centres for its “city quarters” project, which could lead to thousands of new residential units

Killian Woods | 5 days ago

Big tech firm claims EngineNode tried to build facility on lands in Meath owned by Facebook without permission

Killian Woods | 5 days ago

Kerry-based financial services giant has placed two foreign exchange shop brands into administration in recent weeks

Ian Guider | 5 days ago